US 12415861
Anti C-MET antibodies
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 12415861 (Anti C-MET antibodies) held by CENTESSA PHARMACEUTICALS (UK) LIMITED expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CENTESSA PHARMACEUTICALS (UK) LIMITED
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K45/06